20 Microns [20MICRONS] vs Nile [NILE] Detailed Stock Comparison
20 Microns
NSE
Loading...
Nile
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: 20 Microns wins in 10 metrics, Nile wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | 20 Microns | Nile | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.44 | 18.25 | 20 Microns |
| Price-to-Book Ratio | 1.92 | 2.58 | 20 Microns |
| Debt-to-Equity Ratio | 37.97 | 8.48 | Nile |
| PEG Ratio | 1.19 | 20.42 | 20 Microns |
| EV/EBITDA | 8.28 | 11.85 | 20 Microns |
| Profit Margin (TTM) | 6.60% | 3.95% | 20 Microns |
| Operating Margin (TTM) | 10.82% | 7.35% | 20 Microns |
| EBITDA Margin (TTM) | 10.82% | 7.35% | 20 Microns |
| Return on Equity | 14.37% | 14.70% | Nile |
| Return on Assets (TTM) | 8.73% | 11.81% | Nile |
| Free Cash Flow (TTM) | $-448.94M | $-151.92M | Nile |
| Dividend Yield | 0.45% | 0.26% | 20 Microns |
| 1-Year Return | -28.41% | 2.87% | Nile |
| Price-to-Sales Ratio (TTM) | 0.89 | 0.71 | Nile |
| Enterprise Value | $9.59B | $6.66B | 20 Microns |
| EV/Revenue Ratio | 1.03 | 0.73 | Nile |
| Gross Profit Margin (TTM) | 45.44% | 26.03% | 20 Microns |
| Revenue per Share (TTM) | $263 | $3,031 | Nile |
| Earnings per Share (Diluted) | $17.41 | $119.81 | Nile |
| Beta (Stock Volatility) | 0.75 | 0.20 | Nile |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
20 Microns vs Nile Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| 20 Microns | -0.94% | -1.61% | 3.89% | 10.88% | 31.03% | -2.09% |
| Nile | -1.66% | 11.26% | 32.15% | 51.63% | 32.75% | 13.98% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| 20 Microns | -28.41% | 121.52% | 658.64% | 743.39% | 804.33% | 1,917.59% |
| Nile | 2.87% | 306.84% | 640.10% | 945.58% | 2,077.15% | 1,929.26% |
Performance & Financial Health Analysis: 20 Microns vs Nile
| Metric | 20MICRONS | NILE |
|---|---|---|
| Market Information | ||
| Market Cap | ₹8.26B | ₹6.56B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 359,509 | 11,721 |
| 90 Day Avg. Volume | 451,308 | 6,450 |
| Last Close | ₹231.85 | ₹2,091.15 |
| 52 Week Range | ₹158.20 - ₹348.00 | ₹1,303.50 - ₹2,798.00 |
| % from 52W High | -33.38% | -25.26% |
| All-Time High | ₹348.00 (Aug 19, 2024) | ₹2,798.00 (Aug 26, 2024) |
| % from All-Time High | -33.38% | -25.26% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | 0.09% |
| Quarterly Earnings Growth | -0.06% | 0.60% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | 0.04% |
| Operating Margin (TTM) | 0.11% | 0.07% |
| Return on Equity (TTM) | 0.14% | 0.15% |
| Debt to Equity (MRQ) | 37.97 | 8.48 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹121.68 | ₹846.20 |
| Cash per Share (MRQ) | ₹8.87 | ₹2.75 |
| Operating Cash Flow (TTM) | ₹271.62M | ₹-10,537,000 |
| Levered Free Cash Flow (TTM) | ₹623.76M | ₹-222,532,256 |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.45% | 0.26% |
| Last 12-Month Dividend | ₹1.25 | ₹4.00 |
Valuation & Enterprise Metrics Analysis: 20 Microns vs Nile
| Metric | 20MICRONS | NILE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.44 | 18.25 |
| Forward P/E | N/A | 20.42 |
| PEG Ratio | 1.19 | 20.42 |
| Price to Sales (TTM) | 0.89 | 0.71 |
| Price to Book (MRQ) | 1.92 | 2.58 |
| Market Capitalization | ||
| Market Capitalization | ₹8.26B | ₹6.56B |
| Enterprise Value | ₹9.59B | ₹6.66B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.03 | 0.73 |
| Enterprise to EBITDA | 8.28 | 11.85 |
| Risk & Other Metrics | ||
| Beta | 0.75 | 0.20 |
| Book Value per Share (MRQ) | ₹121.68 | ₹846.20 |
Financial Statements Comparison: 20 Microns vs Nile
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | 20MICRONS | NILE |
|---|---|---|
| Revenue/Sales | ₹2.47B | ₹1.90B |
| Cost of Goods Sold | ₹1.35B | ₹1.41B |
| Gross Profit | ₹1.12B | ₹494.56M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹267.54M | ₹139.68M |
| EBITDA | ₹276.00M | ₹139.91M |
| Pre-Tax Income | ₹228.70M | ₹133.44M |
| Income Tax | ₹60.05M | ₹36.38M |
| Net Income (Profit) | ₹168.64M | ₹97.06M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | 20MICRONS | NILE |
|---|---|---|
| Cash & Equivalents | ₹312.98M | ₹8.60M |
| Total Current Assets | ₹3.75B | ₹2.25B |
| Total Current Liabilities | ₹2.19B | ₹226.22M |
| Long-Term Debt | ₹321.53M | ₹126.95M |
| Total Shareholders Equity | ₹4.34B | ₹2.65B |
| Retained Earnings | ₹3.39B | N/A |
| Property, Plant & Equipment | ₹254.97M | ₹615.52M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | 20MICRONS | NILE |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | 20MICRONS | NILE |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 359,509 | 11,721 |
| Average Daily Volume (90 Day) | 451,308 | 6,450 |
| Shares Outstanding | 35.29M | 3.00M |
| Float Shares | 14.55M | 1.01M |
| % Held by Insiders | 0.54% | 0.58% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: 20 Microns vs Nile
| Metric | 20MICRONS | NILE |
|---|---|---|
| Last 12-Month Dividend | ₹1.25 | ₹4.00 |
| Last 12-Month Dividend Yield | 0.45% | 0.26% |
| 3-Year Avg Annual Dividend | ₹1.08 | ₹3.00 |
| 3-Year Avg Dividend Yield | 0.56% | 0.28% |
| 3-Year Total Dividends | ₹3.25 | ₹9.00 |
| Ex-Dividend Date | Jul 24, 2025 | Nov 22, 2024 |